Adma Biologics Company Profile (NASDAQ:ADMA)

About Adma Biologics

ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include Plasma Collection Centers, which includes its operations in Georgia; Research and Development, which includes its plasma development operations in New Jersey, and Corporate. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its intravenous immunoglobulin product candidate, RI-002, is intended for the treatment of primary immune deficiency disease.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: ADMA
CUSIP:

Key Metrics:

Previous Close: $7.32
50 Day Moving Average: $6.06
200 Day Moving Average: $6.65
52-Week Range: $4.15 - $9.85
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -6.08
P/E Growth: 0.00
Market Cap: $94.20M
Outstanding Shares: 12,886,000
Beta: 2.87

Profitability:

Net Margins: -231.85%
Return on Equity: -1,293.57%
Return on Assets: -78.91%

Debt:

Debt-to-Equity Ratio: 4.62%
Current Ratio: 5.81%
Quick Ratio: 4.98%

Additional Links:

Companies Related to Adma Biologics:

Consensus Ratings for Adma Biologics (NASDAQ:ADMA) (?)

Ratings Breakdown:	2 Hold Ratings
Consensus Rating:	Hold (Score: 2.00)
Consensus Price Target:	$14.00 (93.37% upside)

Analysts' Ratings History for Adma Biologics (NASDAQ:ADMA)

Show:

Date	Firm	Action	Rating	Price Target
8/1/2016	Raymond James Financial Inc.	Downgrade	Strong-Buy -> Market Perform
8/1/2016	Maxim Group	Downgrade	Buy -> Hold
12/8/2014	Oppenheimer Holdings Inc.	Initiated Coverage	Outperform	$20.00

(Data available from 9/30/2014 forward)

Earnings History for Adma Biologics (NASDAQ:ADMA)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/8/2016
8/12/2016	Q2	($0.39)	($0.50)			View	N/A
5/13/2016	Q1	($0.37)	($0.43)			View	N/A
3/23/2016	Q415	($0.47)	($0.58)	$30.00 million		View	N/A
11/10/2015	Q315	($0.39)	($0.48)	$1.50 million	$1.85 million	View	N/A
8/11/2015	Q215	($0.36)	($0.44)	$1.50 million	$1.30 million	View	N/A
5/12/2015	Q115	($0.38)	($0.37)	$1.50 million	$1.50 million	View	N/A
3/9/2015		($0.38)	($0.38)			View	N/A
11/10/2014		($0.37)	($0.36)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Adma Biologics (NASDAQ:ADMA)

Current Year EPS Consensus Estimate: $-1.76 EPS
Next Year EPS Consensus Estimate: $-1.19 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q2 2016	1	($0.37)	($0.37)	($0.37)
Q3 2016	1	($0.38)	($0.38)	($0.38)
Q4 2016	1	($0.38)	($0.38)	($0.38)

(Data provided by Zacks Investment Research)

Dividend History for Adma Biologics (NASDAQ:ADMA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Adma Biologics (NASDAQ:ADMA)

Insider Ownership Percentage: 60.44%
Institutional Ownership Percentage: 73.91%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
5/3/2016	Adam S Grossman	CEO	Buy	200,000	$6.50	$1,300,000.00
5/3/2016	Brian Lenz	CFO	Buy	2,500	$6.50	$16,250.00
5/3/2016	James Mond	CMO	Buy	770	$6.50	$5,005.00
5/3/2016	Jerrold B Grossman	Director	Buy	45,769	$6.50	$297,498.50
12/8/2015	Adam S. Grossman	CEO	Buy	500	$9.00	$4,500.00
12/7/2015	Jerrold B Grossman	Director	Buy	500	$9.01	$4,505.00
12/2/2015	Adam S Grossman	CEO	Buy	2,250	$9.15	$20,587.50
12/2/2015	Brian Lenz	CFO	Buy	1,000	$9.15	$9,150.00
12/2/2015	Jerrold B Grossman	Director	Buy	6,000	$9.16	$54,960.00
12/1/2015	Adam S Grossman	CEO	Buy	1,800	$9.17	$16,506.00
11/25/2015	Adam S Grossman	CEO	Buy	1,800	$9.18	$16,524.00
11/20/2015	Adam S Grossman	CEO	Buy	3,861	$9.21	$35,559.81
3/19/2015	Adam S Grossman	CEO	Buy	2,000	$8.50	$17,000.00
3/17/2015	Adam S Grossman	CEO	Buy	5,500	$7.98	$43,890.00
3/17/2015	Jerrold B Grossman	Director	Buy	500	$8.01	$4,005.00
3/16/2015	Adam S Grossman	CEO	Buy	8,800	$8.03	$70,664.00
3/16/2015	James Mond	CMO	Buy	1,250	$8.02	$10,025.00
3/16/2015	Lawrence P Guiheen	Director	Buy	1,000	$7.96	$7,960.00
3/13/2015	Eric I Richman	Director	Buy	3,500	$7.88	$27,580.00
9/12/2014	Adam S Grossman	CEO	Buy	4,300	$9.57	$41,151.00
8/22/2014	Adam S Grossman	CEO	Buy	1,000	$9.50	$9,500.00
8/14/2014	Adam S Grossman	CEO	Buy	2,100	$9.77	$20,517.00
6/18/2014	Adam S Grossman	CEO	Buy	1,875	$9.59	$17,981.25
5/22/2014	Adam S Grossman	CEO	Buy	4,226	$8.15	$34,441.90
5/15/2014	Adam S Grossman	CEO	Buy	13,400	$7.50	$100,500.00
5/14/2014	Brian Lenz	CFO	Buy	1,000	$7.50	$7,500.00
5/14/2014	James Mond	CMO	Buy	1,315	$7.60	$9,994.00
12/10/2013	Jerrold B Grossman	Director	Buy	3,650	$7.30	$26,645.00

(Data available from 1/1/2013 forward)

Latest Headlines for Adma Biologics (NASDAQ:ADMA)

Date	Headline
	Galectin Shares Downgraded As NASH-FX Failure Likely Degrades The Prognosis For NASH-CX (NASDAQ:ADMA) www.benzinga.com - September 30 at 3:44 PM
	ETF’s with exposure to ADMA Biologics, Inc. : September 21, 2016 (NASDAQ:ADMA) www.capitalcube.com - September 21 at 10:50 AM
	ADMA BIOLOGICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:ADMA) biz.yahoo.com - September 10 at 8:04 AM
	Pacira Pharmaceuticals, Inc. to Present at the Morgan Stanley Global ... (NASDAQ:ADMA) www.econotimes.com - September 2 at 5:28 AM
	ADMA Biologics to Present at Upcoming Investor Conferences (NASDAQ:ADMA) finance.yahoo.com - September 1 at 11:45 AM
	Investor News: ADMA Biologics Inc (NASDAQ:ADMA) under Investigation over possible Wrongdoing (NASDAQ:ADMA) www.groundreport.com - August 22 at 8:06 AM
	ADMA BIOLOGICS, INC. Financials (NASDAQ:ADMA) finance.yahoo.com - August 19 at 3:34 PM
	Investor Investigation over Potential Wrongdoing at ADMA Biologics Inc Announced (NASDAQ:ADMA) www.sbwire.com - August 17 at 3:20 PM
	ADMA Biologics : Investor Investigation over Potential Wrongdoing at ADMA Biologics Inc Announced (NASDAQ:ADMA) www.4-traders.com - August 17 at 3:20 PM
	ADMA - Reviewing 2Q:16 Results; Waiting for Clarity on Resubmission Timeline (NASDAQ:ADMA) finance.yahoo.com - August 17 at 3:20 PM
	ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 (NASDAQ:ADMA) www.capitalcube.com - August 16 at 11:55 AM
	BRIEF-ADMA Biologics reports second quarter 2016 results (NASDAQ:ADMA) www.reuters.com - August 13 at 11:16 AM
	ADMA Biologics Reports Second Quarter 2016 Results (NASDAQ:ADMA) www.nasdaq.com - August 13 at 11:16 AM
	Adma Biologics reports 2Q loss (NASDAQ:ADMA) sg.finance.yahoo.com - August 12 at 8:40 PM
	ADMA BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:ADMA) biz.yahoo.com - August 4 at 9:01 PM
	ADMA CRL Isolated to Partner Manufacturing Issues: Anticipate 8 Month Delay (NASDAQ:ADMA) finance.yahoo.com - August 2 at 3:18 PM
	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ADMA Biologics, Inc. (ADMA) (NASDAQ:ADMA) finance.yahoo.com - August 2 at 8:04 AM
	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding Possible Violations of Federal Securities Laws by Certain Officers and Directors of ADMA Biologics, Inc. (NASDAQ:ADMA) finance.yahoo.com - August 2 at 8:04 AM
	INVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims against ADMA Biologics, Inc. and Advises Investors with Losses to Contact the Firm (NASDAQ:ADMA) finance.yahoo.com - August 2 at 8:04 AM
	ADMA Biologics downgraded by Maxim Group (NASDAQ:ADMA) finance.yahoo.com - August 1 at 3:18 PM
	ADMA Biologics tanks 21% as Raymond James downgrades stock (NASDAQ:ADMA) www.marketwatch.com - August 1 at 3:18 PM
	ADMA Biologics Inc (ADMA) Just Gave Us A CRL Opportunity (NASDAQ:ADMA) www.insidermonkey.com - August 1 at 3:18 PM
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA (NASDAQ:ADMA) finance.yahoo.com - August 1 at 3:18 PM
	TKAI Laying Off Staff Big Time, MCRB Plunges, FDA Says No To ADMA (NASDAQ:ADMA) www.rttnews.com - August 1 at 8:05 AM
	4:47 pm ADMA Biologics receives CRL from the FDA over the Biologics License Application for RI-002 for the treatment of patients with Primary Humoral Immunodeficiency Disease (NASDAQ:ADMA) finance.yahoo.com - July 31 at 4:47 PM
	ADMA Biologics Receives Complete Response Letter from FDA for Pending Biologics License Application (NASDAQ:ADMA) finance.yahoo.com - July 29 at 7:14 PM
	A report released today by Maxim Group about ADMA Biologics Inc(NASDAQ:ADMA) drops the target price to $14 (NASDAQ:ADMA) breakingfinancenews.com - July 25 at 3:18 PM
	ETF’s with exposure to ADMA Biologics, Inc. : July 20, 2016 (NASDAQ:ADMA) www.capitalcube.com - July 20 at 12:05 PM
	ADMA Biologics : to Present at the 2016 JMP Securities Life Sciences Conference (NASDAQ:ADMA) www.4-traders.com - June 17 at 3:18 PM
	ADMA Biologics to Present at the 2016 JMP Securities Life Sciences Conference (NASDAQ:ADMA) finance.yahoo.com - June 16 at 7:38 AM
	ADMA BIOLOGICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote o (NASDAQ:ADMA) biz.yahoo.com - June 10 at 5:02 PM
	7 North Jersey entrepreneurs named to EY annual list (NASDAQ:ADMA) www.northjersey.com - June 2 at 11:56 AM
	StayinFront Life Sciences Mobile Cloud Solution Selected by ADMA Biologics as Part of Ongoing Commercialization Infrastructure Buildout (NASDAQ:ADMA) www.marketwired.com - June 2 at 11:56 AM
	ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 (NASDAQ:ADMA) www.capitalcube.com - June 1 at 2:35 PM
	Performance at a Glance on ADMA Biologics, Inc. (NASDAQ:ADMA) - HNN (NASDAQ:ADMA) hintsnewsnetwork.com - May 30 at 6:34 PM
	ADMA Biologics Inc (NASDAQ:ADMA) Impact Score At 0 - RealistInvestor.com (NASDAQ:ADMA) www.realistinvestor.com - May 30 at 6:34 PM
	ADMA BIOLOGICS (NASDAQ:ADMA) Institutional Investor Sentiment - Wall Street Hints and News (NASDAQ:ADMA) hintsnewsnetwork.com - May 25 at 2:49 PM
	Target Check and Stock Performance Recap ADMA Biologics Inc (NASDAQ:ADMA) - Wall Street Hints and News (NASDAQ:ADMA) hintsnewsnetwork.com - May 25 at 2:49 PM
	Earnings Review and Stock Rundown for ADMA Biologics Inc (NASDAQ:ADMA) - Wall Street Hints and News (NASDAQ:ADMA) hintsnewsnetwork.com - May 25 at 2:49 PM
	Broker Outlook For ADMA Biologics Inc (ADMA) - Share Trading News (NASDAQ:ADMA) www.sharetrading.news - May 21 at 2:33 PM
	ADMA: Additional Capital Raised; Plasma Center Collections Escalating (NASDAQ:ADMA) finance.yahoo.com - May 19 at 3:00 PM
	Share Recap and Earnings Focus on ADMA Biologics Inc (NASDAQ:ADMA) - Wall Street Hints and News (NASDAQ:ADMA) hintsnewsnetwork.com - May 19 at 2:34 PM
	BRIEF-Adma Biologics Q1 loss per share $0.43 - Reuters (NASDAQ:ADMA) www.reuters.com - May 14 at 8:50 AM
	ADMA Biologics (ADMA) Recieves $4M in Capital Through Amended Loan and Security Agreement with Oxford Finance - StreetInsider.com (NASDAQ:ADMA) www.streetinsider.com - May 14 at 8:50 AM
	ADMA Biologics (ADMA) Recieves $4M in Capital Through Amended Loan and Security Agreement with Oxford Finance (NASDAQ:ADMA) www.streetinsider.com - May 14 at 8:50 AM
	Funds to be Utilized to Advance Company’s RI-002 Commercialization Efforts and Expand Plasma Center Network (NASDAQ:ADMA) www.einnews.com - May 14 at 8:50 AM
	Adma Biologics reports 1Q loss (NASDAQ:ADMA) sg.finance.yahoo.com - May 13 at 5:16 PM
	ADMA Biologics Reports First Quarter 2016 Results (NASDAQ:ADMA) finance.yahoo.com - May 13 at 5:05 PM
	ADMA Biologics Further Enhances Cash Position by Securing $4.0 Million in Additional Capital Through Amended Loan and Security Agreement with Oxford Finance (NASDAQ:ADMA) finance.yahoo.com - May 13 at 4:05 PM
	Check on Analyst Ratings ADMA Biologics Inc (NASDAQ:ADMA) - B.O.D.Y Confidential (NASDAQ:ADMA) www.bodyconfidential.com - May 10 at 9:10 AM